- Home
- BHST vs FDMT Comparison
BHST vs FDMT Comparison
Compare BHST & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- FDMT
- Stock Information
- Founded
- BHST 2007
- FDMT 2013
- Country
- BHST Canada
- FDMT United States
- Employees
- BHST N/A
- FDMT N/A
- Industry
- BHST
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- BHST
- FDMT Health Care
- Exchange
- BHST Nasdaq
- FDMT Nasdaq
- Market Cap
- BHST 166.4M
- FDMT 192.2M
- IPO Year
- BHST N/A
- FDMT 2020
- Fundamental
- Price
- BHST $7.43
- FDMT $7.13
- Analyst Decision
- BHST Strong Buy
- FDMT Buy
- Analyst Count
- BHST 2
- FDMT 9
- Target Price
- BHST $13.00
- FDMT $30.63
- AVG Volume (30 Days)
- BHST 21.0K
- FDMT 750.8K
- Earning Date
- BHST 08-11-2025
- FDMT 08-11-2025
- Dividend Yield
- BHST N/A
- FDMT N/A
- EPS Growth
- BHST N/A
- FDMT N/A
- EPS
- BHST N/A
- FDMT N/A
- Revenue
- BHST $30,192,000.00
- FDMT $33,000.00
- Revenue This Year
- BHST $116.40
- FDMT $9,921.62
- Revenue Next Year
- BHST $55.91
- FDMT N/A
- P/E Ratio
- BHST N/A
- FDMT N/A
- Revenue Growth
- BHST 57.83
- FDMT N/A
- 52 Week Low
- BHST $4.66
- FDMT $2.24
- 52 Week High
- BHST $9.90
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- BHST 39.26
- FDMT 62.56
- Support Level
- BHST $7.10
- FDMT $6.09
- Resistance Level
- BHST $9.45
- FDMT $7.33
- Average True Range (ATR)
- BHST 0.50
- FDMT 0.50
- MACD
- BHST -0.21
- FDMT -0.03
- Stochastic Oscillator
- BHST 13.47
- FDMT 81.12
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.